Metraipolis › archive › dc_bb2af6893405
Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025 — Europe PMC PMID:41641272
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41641272
- DOI
- 10.3389/fimmu.2025.1716090
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T16:25:56.582Z
- SHA-256 of the archived text
ea6796213e0fc9d4320dbbe114711166bf870c6bab336b2dccb48f7cd0f24277- Stable URL of this page
https://metraipolis.com/documento/dc_bb2af6893405
How to cite
Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025 — Europe PMC PMID:41641272 — Europe PMC (en), https://europepmc.org/article/MED/41641272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb2af6893405 (Metraipolis archive dc_bb2af6893405, sha256 ea6796213e0fc9d4320dbbe114711166bf870c6bab336b2dccb48f7cd0f24277)
BibTeX
@misc{dcbb2af6893405,
title = {Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010-2025 — Europe PMC PMID:41641272},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41641272},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb2af6893405; sha256 ea6796213e0fc9d4320dbbe114711166bf870c6bab336b2dccb48f7cd0f24277},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41641272. Agents can read the archived copy with the MCP tool read_document.